Mingliang Wang

Lei Zhang, Mingliang Wang, Xin Zhou et al.

Delivery Time Estimation (DTE) is a crucial component of the e-commerce supply chain that predicts delivery time based on merchant information, sending address, receiving address, and payment time. Accurate DTE can boost platform revenue and reduce customer complaints and refunds. However, the imbalanced nature of industrial data impedes previous models from reaching satisfactory prediction performance. Although imbalanced regression methods can be applied to the DTE task, we experimentally find that they improve the prediction performance of low-shot data samples at the sacrifice of overall performance. To address the issue, we propose a novel Dual Graph Multitask framework for imbalanced Delivery Time Estimation (DGM-DTE). Our framework first classifies package delivery time as head and tail data. Then, a dual graph-based model is utilized to learn representations of the two categories of data. In particular, DGM-DTE re-weights the embedding of tail data by estimating its kernel density. We fuse two graph-based representations to capture both high- and low-shot data representations. Experiments on real-world Taobao logistics datasets demonstrate the superior performance of DGM-DTE compared to baselines.

Li Zhang, Mingliang Wang, Mingxia Liu et al.

Deep learning has been recently used for the analysis of neuroimages, such as structural magnetic resonance imaging (MRI), functional MRI, and positron emission tomography (PET), and has achieved significant performance improvements over traditional machine learning in computer-aided diagnosis of brain disorders. This paper reviews the applications of deep learning methods for neuroimaging-based brain disorder analysis. We first provide a comprehensive overview of deep learning techniques and popular network architectures, by introducing various types of deep neural networks and recent developments. We then review deep learning methods for computer-aided analysis of four typical brain disorders, including Alzheimer's disease, Parkinson's disease, Autism spectrum disorder, and Schizophrenia, where the first two diseases are neurodegenerative disorders and the last two are neurodevelopmental and psychiatric disorders, respectively. More importantly, we discuss the limitations of existing studies and present possible future directions.